生物标志物 生物标志物
Catarina Tristão-Pereira1,2, Ana Y Baena3, Natalia Londono4
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
轻度行为障碍 (MBI) 在患有自体主导阿尔茨海默病 (AD) 突变的个体中更为常见. MBI与大脑葡萄糖代谢减少有关,这表明它可能预测AD早期的神经退行和认知衰退.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 老年学是一门学科.
背景情况:
- 神经精神症状在痴呆症中很常见,通常在早期出现.
- 在非痴呆症患者中,轻度行为障碍 (MBI) 显示了与神经退行症的可变联系.
- 这项研究检查了MBI与大脑葡萄糖代谢在自体主导阿尔茨海默病 (AD) 的关系.
研究的目的:
- 研究轻度行为障碍 (MBI) 与大脑葡萄糖代谢之间的关联.
- 探索MBI作为自体主导阿尔茨海默病 (AD) 中神经退行症的潜在早期指标的作用.
- 为了确定阿尔茨海默氏病的病理学中介于MBI和大脑新陈代谢之间的关系.
主要方法:
- 利用了来自哥伦比亚 - 波士顿 (COLBOS) 生物标志物研究的数据,包括Presenilin-1 E280A突变载体和非载体.
- 使用MBI-Checklist (MBI-C) 评估MBI,并通过在前皮质中使用18F-氧糖 (FDG) PET测量大脑葡萄糖代谢.
- 通过使用粉样蛋白和蛋白PET数据进行调解分析,以评估AD病理学的作用.
主要成果:
- 携带突变 (68%) 的MBI阳性显著高于非携带者 (35%).
- 患有MBI的参与者表现出降低前性葡萄糖代谢 (FDG吸收),特别是在携带者中.
- 阿尔茨海默病的病理学部分调解了MBI和减少FDG摄入之间的关联.
结论:
- 在突变载体中,MBI与早期AD相关区域的低代谢有关,部分原因是AD病理.
- 这些发现表明MBI可能会先于神经退行和认知障碍,可能成为AD进展的早期风险因素.
- 需要进行更大样本规模的进一步研究,以验证MBI作为识别患AD高风险个体和预防策略的标记.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516